CVR number 41060581
Industry 86.9020 Other human health activities

Autoriseret fysioterapeut Majken Lysdal ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2017
N/A
2018
N/A
2019
N/A
2020
2021/6
2021
2022/6
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 0.0% 0.0% 11.0% 13.6%  
Credit score (0-100)  0 0 0 22 15  
Credit rating  N/A N/A N/A BB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2017
N/A
2018
N/A
2019
N/A
2020
2021/6
2021
2022/6
Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 0.0 188 352  
EBITDA  0.0 0.0 0.0 48.6 -5.5  
EBIT  0.0 0.0 0.0 48.6 -5.5  
Pre-tax profit (PTP)  0.0 0.0 0.0 48.6 -6.1  
Net earnings  0.0 0.0 0.0 37.2 -6.1  
Pre-tax profit without non-rec. items  0.0 0.0 0.0 48.6 -6.1  
 
See the entire income statement

Balance sheet (kDKK) 
2017
N/A
2018
N/A
2019
N/A
2020
2021/6
2021
2022/6
Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  0.0 0.0 0.0 77.2 71.1  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0.0 0.0 0.0 146 182  
Net Debt  0.0 0.0 0.0 -59.0 -47.3  
 
See the entire balance sheet

Volume 
2017
N/A
2018
N/A
2019
N/A
2020
2021/6
2021
2022/6
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 0.0 188 352  
Gross profit growth  0.0% 0.0% 0.0% 0.0% 87.1%  
Employees  0 0 0 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 0 146 182  
Balance sheet change%  0.0% 0.0% 0.0% 0.0% 24.8%  
Added value  0.0 0.0 0.0 48.6 -5.5  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 0.0 1.0 -1.0  

Profitability 
2017
N/A
2018
N/A
2019
N/A
2020
2021/6
2021
2022/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 0.0% 25.9% -1.6%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% 0.0% 33.4% -3.4%  
ROI %  0.0% 0.0% 0.0% 63.0% -7.5%  
ROE %  0.0% 0.0% 0.0% 48.2% -8.3%  

Solidity 
2017
N/A
2018
N/A
2019
N/A
2020
2021/6
2021
2022/6
Equity ratio %  0.0% 0.0% 0.0% 53.0% 39.1%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% 0.0% -121.3% 854.1%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2017
N/A
2018
N/A
2019
N/A
2020
2021/6
2021
2022/6
Quick Ratio  0.0 0.0 0.0 2.1 1.6  
Current Ratio  0.0 0.0 0.0 2.1 1.6  
Cash and cash equivalent  0.0 0.0 0.0 59.0 47.3  

Capital use efficiency 
2017
N/A
2018
N/A
2019
N/A
2020
2021/6
2021
2022/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 0.0 77.2 71.1  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2017
N/A
2018
N/A
2019
N/A
2020
2021/6
2021
2022/6
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 49 -6  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 49 -6  
EBIT / employee  0 0 0 49 -6  
Net earnings / employee  0 0 0 37 -6